Jacobs Levy Equity Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Sell |
|
|||||
|
2025
Q1 | $851K | Buy |
|
|||||
|
2024
Q4 | $757K | Sell |
|
|||||
|
2024
Q3 | $1.27M | Sell |
|
|||||
|
2024
Q2 | $1.06M | Buy |
|
|||||
|
2024
Q1 | $129K | Sell |
|
|||||
|
2023
Q4 | $548K | Buy |
|
|||||
|
2023
Q3 | $242K | Buy |
|
|||||
|
2023
Q2 | $270K | Sell |
|
|||||
|
2023
Q1 | $919K | Buy |
|
|||||
|
2022
Q4 | $369K | Sell |
|
|||||
|
2022
Q3 | $636K | Buy |
|
|||||
|
2022
Q2 | $410K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $665K | Buy |
|
|||||
|
2017
Q3 | $470K | Buy |
|